首页> 外国专利> Forms of oral drug-resistant dosage, including an antagonist and / or opioid resistance, a tar oxidizer, and a polymer anionico

Forms of oral drug-resistant dosage, including an antagonist and / or opioid resistance, a tar oxidizer, and a polymer anionico

机译:口服耐药剂的形式,包括拮抗剂和/或阿片类药物的耐药性,焦油氧化剂和聚合物阴离子型

摘要

It refers to an anti rupture drug in the oral medicine, with the anti rupture ability up to 300 newtons, including: (1) an active component of the medicine, such as oxycodone; (2) an opioid antagonist, such as nabinylexone, naloxone, nanophene, etc.; and (or) an anti rupture agent; (3) a multi tar oxidant, including: Its average molecular weight is 200000 g / molecule; and (IV) an anionic polymer composed of cationic functional groups such as carbohydrate group, sulfate group and phosphate group; in addition, a plasticizer and an antioxidant.
机译:它是一种口服药物中的抗破裂药,具有高达300牛顿的抗破裂能力,包括:(1)药物的活性成分,如羟考酮; (2)阿片类拮抗剂,例如萘比洛酮,纳洛酮,纳酚等;和(或)抗破裂剂; (3)多元焦油氧化剂,包括:其平均分子量为200000 g /分子; (IV)由碳水化合物,硫酸根,磷酸根等阳离子性官能团构成的阴离子性聚合物。此外,还有增塑剂和抗氧化剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号